Osaka, Japan

Motonari Uesugi

This inventor holds 13 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Metabolic Disorders. Top assignees: Baylor College of Medicine, Fgh Biotech, Inc., Other. Active years: 2006-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Motonari Uesugi. Retrieved from https://idiyas.com/inventor/motonari-uesugi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 13 

% Patents Active = 76.9

 


Average Co-Inventor Count = 3.3

ph-index = 4

Forward Citations = 40(Granted Patents)


Location History:

  • Houston, TX (US) (2006 - 2015)
  • Osaka, JP (2015 - 2022)

Company Filing History:


Years Active: 2006-2022

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Di-Substituted Pyrazole
Fatostatin Compounds
Cancer Treatment
Hyperproliferative Disorders
Body Weight Disorders
Metabolic Disorders
Small Molecule Inhibitors
HER2 Expression
13 patents (USPTO):Explore Patents

Title: Motonari Uesugi: Innovator in Pharmaceutical Compounds

Introduction

Motonari Uesugi is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating various diseases. With a total of 13 patents, Uesugi's work has the potential to impact the treatment of metabolic disorders and other health conditions.

Latest Patents

Uesugi's latest patents include innovative di-substituted pyrazole compounds designed for the treatment of diseases. These compounds are part of pharmaceutical compositions that target conditions associated with abnormal activation of the SREBP pathway. This includes metabolic disorders such as obesity, cancer, cardiovascular disease, and nonalcoholic fatty liver disease (NAFLD). The compounds are described in detail according to a specific formula, showcasing their potential therapeutic applications.

Career Highlights

Throughout his career, Uesugi has worked with notable institutions, including Baylor College of Medicine and FGH Biotech, Inc. His research and development efforts have led to advancements in the pharmaceutical industry, particularly in the area of metabolic disease treatment.

Collaborations

Uesugi has collaborated with esteemed colleagues such as Salih J Wakil and Lutfi Abu-Elheiga. These partnerships have further enhanced his research capabilities and contributed to the success of his innovative projects.

Conclusion

Motonari Uesugi stands out as a key figure in the development of pharmaceutical innovations. His work on di-substituted pyrazole compounds exemplifies his commitment to addressing critical health issues through scientific research and innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…